Evaluation of efficacy and safety of Liv. 52 DS tablets in acute viral hepatitis: A prospective, double-blind, randomized, placebo-controlled, phase III clinical trial

Research output: Contribution to journalArticle

Original languageUndefined
JournalMedicine
StatePublished - 2004

Cite this

@article{a411b27579644709b5a85cbc5116c755,
title = "Evaluation of efficacy and safety of Liv. 52 DS tablets in acute viral hepatitis: A prospective, double-blind, randomized, placebo-controlled, phase III clinical trial",
author = "Nikhil Patel",
year = "2004",
language = "Undefined",
journal = "Medicine",
issn = "1357-3039",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Evaluation of efficacy and safety of Liv. 52 DS tablets in acute viral hepatitis: A prospective, double-blind, randomized, placebo-controlled, phase III clinical trial

AU - Patel, Nikhil

PY - 2004

Y1 - 2004

M3 - Article

JO - Medicine

JF - Medicine

SN - 1357-3039

ER -